Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections [0.03%]
潜在的免疫纳米医学策略对抗类似COVID-19的肺部感染
Srinivasa Reddy Bonam,Niranjan G Kotla,Raghvendra A Bohara et al.
Srinivasa Reddy Bonam et al.
COVID-19, coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this (October 14, 2020), more than 38.4 million people have become affected, and 1....
Jiarong Zhou,Nishta Krishnan,Yao Jiang et al.
Jiarong Zhou et al.
The continued emergence of novel viruses poses a significant threat to global health. Uncontrolled outbreaks can result in pandemics that have the potential to overburden our healthcare and economic systems. While vaccination is a conventio...
Ayça Bal-Ozturk,Berivan Cecen,Meltem Avci-Adali et al.
Ayça Bal-Ozturk et al.
Sutures, staples, clips and skin closure strips are used as the gold standard to close wounds after an injury. In spite of being the present standard of care, the utilization of these conventional methods is precarious amid complicated and ...
Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery [0.03%]
通过高内皮微静脉靶向递送同时针对原发肿瘤、引流淋巴结和远处转移灶的作用
Liwei Jiang,Sungwook Jung,Jing Zhao et al.
Liwei Jiang et al.
Cancer patients with malignant involvement of tumor-draining lymph nodes (TDLNs) and distant metastases have the poorest prognosis. A drug delivery platform that targets the primary tumor, TDLNs, and metastatic niches simultaneously, remain...
Stimuli-Responsive Plasmonic Assemblies and Their Biomedical Applications [0.03%]
刺激响应型等离激元组装体及其生物医学应用
Qinrui Fu,Zhi Li,Fengfu Fu et al.
Qinrui Fu et al.
Among the diverse development of stimuli-responsive assemblies, plasmonic nanoparticle (NP) assemblies functionalized with responsive molecules are of a major interest. In this review, we outline a comprehensive and up-to-date overview of r...
Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)? [0.03%]
使用纳米硒对抗新型冠状病毒肺炎（COVID-19）？
Lina He,Jiating Zhao,Liming Wang et al.
Lina He et al.
The coronavirus disease 2019 (COVID-19) pandemic represents a severe global health threat. Selenium (Se), as one of the essential trace elements in human body, is well known for its antioxidant and immunity-boosting capabilities that induce...
Selective Trafficking of Light Chain-Conjugated Nanoparticles to the Kidney and Renal Cell Carcinoma [0.03%]
选择性地将轻链-连接的纳米颗粒靶向递送至肾脏和肾细胞癌
Farideh Ordikhani,Vivek Kasinath,Mayuko Uehara et al.
Farideh Ordikhani et al.
Specific delivery platforms for drugs to the kidney and diagnostic agents to renal cell carcinoma (RCC) constitute urgent but unfulfilled clinical needs. To address these challenges, we engineered nanocarriers that interact selectively for ...
Zhongmin Tang,Xingcai Zhang,Yiqing Shu et al.
Zhongmin Tang et al.
In just a few months, SARS-CoV-2 and the disease it causes, COVID-19, created a worldwide pandemic. Virologists, biologists, pharmacists, materials scientists, and clinicians are collaborating to develop efficient treatment strategies. Over...
I R S Ribeiro,R F da Silva,C P Silveira et al.
I R S Ribeiro et al.
The lack of targeting efficacy has frequently led functionalized nanoparticles to accumulate in unwanted cells and tissues while boosting toxicity-related effects. Conversely, viruses are natural nanoparticles that precisely and responsivel...
Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy [0.03%]
用于血栓治疗的仿生纤维蛋白靶向和H2O2响应纳米载体
Yi Zhao,Ruosen Xie,Nisakorn Yodsanit et al.
Yi Zhao et al.
Thrombosis is a principle cause of various life-threatening cardiovascular diseases. However, current antithrombotic treatments using drugs only offer limited efficacy due to short half-life, low targeting ability to the thrombus site, and ...